TITAN MEDICAL WKN: A2JN66 ISIN: CA88830X8199 Kürzel: QTNA Forum: Aktien Thema: Hauptdiskussion

Ein RS ist selten was gutes, und hier gabs 2018 einen 30:1,also von 30000 shares sind da noch 1000 übrig, und da kannst dir mal ausrechnen was das noch wert ist 🤢

Aber habe mich selbst noch nicht näher mit beschäftigt.

Würde ich jetzt nicht so nachteilig sehen. Geht doch wahrscheinlich wieder um die Notierung?

Es ist leider nur langsam schon dringend, hab mich selbst noch nicht so informiert, aber es soll gerade bezüglich einem RS diskutiert werden 🙄

Ich denke, dass noch Geduld gefragt sein wird - lasse mich aber gerne vom Gegenteil überzeugen 🙃

Danke, hoffentlich gehts da jetzt bald mal nach oben 🙄

Titan Medical Reveals New Robotic Surgical System Brand Identity and Updated Corporate Brand Identity https://www.businesswire.com/news/home/20200921005103/en/Titan-Medical-Reveals-New-Robotic-Surgical-System-Brand-Identity-and-Updated-Corporate-Brand-Identity ...announced today the launch of a new name and brand identity for its robotic surgical system under development, the Enos™ robotic single access surgical system.

Titan Medical Announces Intellectual Property Portfolio Expansion with Issuance of Robotic Surgery Patents Related to Camera and System Control https://www.businesswire.com/news/home/20200917005255/en/Titan-Medical-Announces-Intellectual-Property-Portfolio-Expansion-with-Issuance-of-Robotic-Surgery-Patents-Related-to-Camera-and-System-Control Bzw. Titan Medical bags two new patents in U.S. https://seekingalpha.com/news/3614937 • Titan Medical (NASDAQ:TMDI) has recently been issued two U.S. patents, increasing its global intellectual property portfolio to 58 issued patents and 84 patent applications. • Included in the recent patent issuances is U.S. Patent No. 10,772,703 titled “Methods and apparatuses for positioning a camera of a surgical robotic system to capture images inside a body cavity of a patient during a medical procedure” and • U.S. Patent No. 10,758,311 titled “Hand controller apparatus for gesture control and shared input control in a robotic surgery system.” • The ‘703 patent is directed at the autonomous positioning of a camera in response to the location of a surgical instrument while the ‘311 patent is directed at a novel robotic hand controller with an integrated gesture control pad used to control robotic functions.

Titan Medical Announces Chief Financial Officer Retirement and Successor Appointment https://www.businesswire.com/news/home/20200908005127/en/Titan-Medical-Announces-Chief-Financial-Officer-Retirement

https://finance.yahoo.com/news/titan-medical-inc-present-ld-130000400.html

Titan Medical Reports Second Quarter 2020 Financial Results https://www.businesswire.com/news/home/20200812005715/en/Titan-Medical-Reports-Quarter-2020-Financial-Results bzw in Kurzform: Titan Medical reports Q2 results https://seekingalpha.com/news/3604898-titan-medical-reports-q2-results Titan Medical (NASDAQ:TMDI): Q2 GAAP EPS of -$0.02. Revenue of $10M. Cash and cash equivalents of $28.68M

Titan Medical Confirms Receipt of Deficiency Notice From Nasdaq https://finance.yahoo.com/news/titan-medical-confirms-receipt-deficiency-000000660.html today announced that on August 5, 2020, the Company received a deficiency notice from the Nasdaq Stock Market LLC ("Nasdaq") Listing Qualifications Department that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5550(a)(2) since the closing bid price for the Company's common shares (the "Shares") listed on Nasdaq was below US$1.00 for 30 consecutive business days. ... The Company is also listed on the Toronto Stock Exchange (the "TSX") and the notification letter does not affect the Company's compliance status with the TSX. The Company intends to evaluate all available options to resolve this deficiency and regain compliance with Nasdaq Rule 5550(a)(2).

https://www.businesswire.com/news/home/20200730005268/en/Titan-Medical-Reports-Design-Enhancements-Single-Port-Robotic Titan Medical Reports Design Enhancements to Single-Port Robotic Surgical Instruments on Product Development Resumption

Titan Medical to Present at the Society of Robotic Surgery 2020 World Robotic Symposium https://www.businesswire.com/news/home/20200727005151/en/Titan-Medical-Present-Society-Robotic-Surgery-2020

👍

Shareholder letter Durchfinanziert für ein ganzes Jahr Gibt raum, dass der kurs soweit steigt, dass die warrants ins geld kommen, was klasse wäre, da damit ein weiteres offering länger überflüssig wäre